These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 10376798)

  • 21. Evidence for different mechanisms of EMT-6 tumor necrosis by photodynamic therapy with disulfonated aluminum phthalocyanine or photofrin: tumor cell survival and blood flow.
    Chan WS; Brasseur N; La Madeleine C; van Lier JE
    Anticancer Res; 1996; 16(4A):1887-92. PubMed ID: 8712717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In situ Fc receptor-bearing cells in two murine tumors. II. Role in tumor immunity.
    Korn JH; Haskill JS; Holden HT; Radov LA; Ritter FL
    J Natl Cancer Inst; 1978 Jun; 60(6):1391-7. PubMed ID: 306442
    [No Abstract]   [Full Text] [Related]  

  • 23. Altered expression of interleukin 6 and interleukin 10 as a result of photodynamic therapy in vivo.
    Gollnick SO; Liu X; Owczarczak B; Musser DA; Henderson BW
    Cancer Res; 1997 Sep; 57(18):3904-9. PubMed ID: 9307269
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiangiogenic treatment enhances photodynamic therapy responsiveness in a mouse mammary carcinoma.
    Ferrario A; von Tiehl KF; Rucker N; Schwarz MA; Gill PS; Gomer CJ
    Cancer Res; 2000 Aug; 60(15):4066-9. PubMed ID: 10945611
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nature, function and distribution of inflammatory cells in regressing and progressing Moloney sarcomas.
    Russell SW; Gillespie GY
    J Reticuloendothel Soc; 1977 Aug; 22(2):159-68. PubMed ID: 72153
    [No Abstract]   [Full Text] [Related]  

  • 26. Cancer treatment by photodynamic therapy combined with adoptive immunotherapy using genetically altered natural killer cell line.
    Korbelik M; Sun J
    Int J Cancer; 2001 Jul; 93(2):269-74. PubMed ID: 11410876
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synchrotron microbeam radiotherapy evokes a different early tumor immunomodulatory response to conventional radiotherapy in EMT6.5 mammary tumors.
    Yang Y; Swierczak A; Ibahim M; Paiva P; Cann L; Stevenson AW; Crosbie JC; Anderson RL; Rogers PAW
    Radiother Oncol; 2019 Apr; 133():93-99. PubMed ID: 30935588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor oxygenation changes post-photodynamic therapy.
    Chen Q; Chen H; Hetzel FW
    Photochem Photobiol; 1996 Jan; 63(1):128-31. PubMed ID: 8577865
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potentiation of the anti-tumour effects of Photofrin-based photodynamic therapy by localized treatment with G-CSF.
    Gołab J; Wilczyński G; Zagozdzon R; Stokłosa T; Dabrowska A; Rybczyńska J; Wasik M; Machaj E; Ołda T; Kozar K; Kamiński R; Giermasz A; Czajka A; Lasek W; Feleszko W; Jakóbisiak M
    Br J Cancer; 2000 Apr; 82(8):1485-91. PubMed ID: 10780531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specific (EMT6) and non-specific (WEHI-164) cytolytic activity by host cells infiltrating tumour spheroids.
    Wilson KM; Lord EM
    Br J Cancer; 1987 Feb; 55(2):141-6. PubMed ID: 3493024
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Celecoxib and NS-398 enhance photodynamic therapy by increasing in vitro apoptosis and decreasing in vivo inflammatory and angiogenic factors.
    Ferrario A; Fisher AM; Rucker N; Gomer CJ
    Cancer Res; 2005 Oct; 65(20):9473-8. PubMed ID: 16230411
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymphocytic infiltration and cytotoxicity under hypoxic conditions in the EMT6 mouse mammary tumor.
    Loeffler DA; Keng PC; Baggs RB; Lord EM
    Int J Cancer; 1990 Mar; 45(3):462-7. PubMed ID: 2307536
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of neutrophils and lymphocytes in inhibition of a mouse mammary adenocarcinoma engineered to release IL-2, IL-4, IL-7, IL-10, IFN-alpha, IFN-gamma, and TNF-alpha.
    Musiani P; Allione A; Modica A; Lollini PL; Giovarelli M; Cavallo F; Belardelli F; Forni G; Modesti A
    Lab Invest; 1996 Jan; 74(1):146-57. PubMed ID: 8569177
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of immune cell infiltration into murine SCCVII tumour by photofrin-based photodynamic therapy.
    Krosl G; Korbelik M; Dougherty GJ
    Br J Cancer; 1995 Mar; 71(3):549-55. PubMed ID: 7880738
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-resolution PET imaging for in vivo monitoring of tumor response after photodynamic therapy in mice.
    Lapointe D; Brasseur N; Cadorette J; La Madeleine C; Rodrigue S; van Lier JE; Lecomte R
    J Nucl Med; 1999 May; 40(5):876-82. PubMed ID: 10319764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of the immune system in mediating the antitumor effect of benzophenothiazine photodynamic therapy.
    Hendrzak-Henion JA; Knisely TL; Cincotta L; Cincotta E; Cincotta AH
    Photochem Photobiol; 1999 May; 69(5):575-81. PubMed ID: 10333764
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early assessment of tumor response to photodynamic therapy using combined diffuse optical and diffuse correlation spectroscopy to predict treatment outcome.
    Thong PSP; Lee K; Toh HJ; Dong J; Tee CS; Low KP; Chang PH; Bhuvaneswari R; Tan NC; Soo KC
    Oncotarget; 2017 Mar; 8(12):19902-19913. PubMed ID: 28423634
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Macrophages as effector cells in interleukin 12-induced T cell-dependent tumor rejection.
    Tsung K; Dolan JP; Tsung YL; Norton JA
    Cancer Res; 2002 Sep; 62(17):5069-75. PubMed ID: 12208763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of T-lymphocytes in the stimulatory effects of EMT6 tumors on medullary pluripotent stem cells of BALB/c mice.
    Fache MP; Lepault F; Frindel E
    Cancer Res; 1982 May; 42(5):1922-6. PubMed ID: 6978178
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Definitive activation of endogenous antitumor immunity by repetitive cycles of cyclophosphamide with interspersed Toll-like receptor agonists.
    Manrique SZ; Dominguez AL; Mirza N; Spencer CD; Bradley JM; Finke JH; Lee JJ; Pease LR; Gendler SJ; Cohen PA
    Oncotarget; 2016 Jul; 7(28):42919-42942. PubMed ID: 27341020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.